NURIX THERAPEUTICS, INC. (NRIX) FY2026 Q3 Balance Sheet
As of 2026-08-31
Balance Sheet
As of 2026-08-31
Swipe to see the full flow
Chart details
NURIX THERAPEUTICS, INC. (NRIX) FY2026 Q3 Balance Sheet
Balance sheet as of 2026-08-31. The chart shows assets, liabilities and equity at that date.
- Assets
- 1,195,298,000 US dollars
- Current assets
- 1,103,692,000 US dollars
- Non-current assets
- 91,606,000 US dollars
- Liabilities
- 226,987,000 US dollars
- Current liabilities
- 130,742,000 US dollars
- Non-current liabilities
- 96,245,000 US dollars
- Equity
- 968,311,000 US dollars
- Cash and cash equivalents
- 720,242,000 US dollars
- Marketable securities, current
- 328,013,000 US dollars
- Prepaid expenses and other current assets
- 35,437,000 US dollars
- Accounts receivable
- 20,000,000 US dollars
- Operating lease right-of-use assets
- 48,631,000 US dollars
- Property and equipment, net
- 19,407,000 US dollars
- Marketable securities, non‑current
- 14,832,000 US dollars
- Other assets
- 7,954,000 US dollars
- Restricted cash
- 782,000 US dollars
- Accrued expenses and other current liabilities
- 63,674,000 US dollars
- Accounts payable
- 32,984,000 US dollars
- Deferred collaboration funding, current
- 22,233,000 US dollars
- Deferred revenue, current
- 8,610,000 US dollars
- Operating lease liabilities, current
- 3,241,000 US dollars
- Operating lease liabilities, net of current portion
- 62,091,000 US dollars
- Deferred collaboration funding, net of current portion
- 23,376,000 US dollars
- Deferred revenue, net of current portion
- 10,778,000 US dollars
- Additional paid-in capital
- 1,598,540,000 US dollars
- Common stock, $0.001 par value— 500,000,000 shares authorized as of August 31, 2026 and November 30, 2025; 109,200,394 and 101,807,484 shares issued and outstanding as of August 31, 2026 and November 30, 2025, respectively
- 109,000 US dollars
- Preferred stock, $0.001 par value— 10,000,000 shares authorized as of August 31, 2026 and November 30, 2025; no shares issued and outstanding as of August 31, 2026 and November 30, 2025
- 0 US dollars
- Accumulated deficit
- negative 630,128,000 US dollars
- Accumulated other comprehensive income (loss)
- negative 210,000 US dollars
- Gross equity (calculated)
- 1,598,649,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.
Chart connections
- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.

Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG
Product waitlist
Health Check and Teardown for your own company
A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!
